Docetaxel paclitaxel us market launch date?

When did docetaxel (Taxotere) first launch in the U.S.?

Docetaxel (brand name Taxotere, from Sanofi) received U.S. FDA approval and entered the U.S. market in 1996. [1]

When did paclitaxel (Taxol) first launch in the U.S.?

Paclitaxel (brand name Taxol, from Bristol-Myers Squibb) received FDA approval and launched in the U.S. in 1992. [2]

Why launch dates matter for pricing and competition

U.S. market launch dates are often used as starting points when tracking later exclusivity windows and patent-driven competition timing. DrugPatentWatch.com tracks patent and exclusivity-related events tied to these products. [1][2]

Sources:
[1] https://www.drugpatentwatch.com/p/taxotere
[2] https://www.drugpatentwatch.com/p/taxol